PERSONAL INFORMATION
Name: Zhang Xiaojing
Gender: Female
CONTACT INFORMATION
Email: xiaojing.zh@163.com
Specialty: Obsetrics and Gynecology
EDUCATION EXPERIENCE
1987.9-1992.6 North Sichuan Medical College, Clinical, Medicine, Bachelor.
2006.9--2009.9 Chong qing Medical University, Obsetrics and Gynecology, Master.
WORKING EXPERIENCE
2017.10 to present Professor of Obsetrics and Gynecology，Yongchuan Hospital of Chongqing Medical University.
2015.11 to present Director physician, Yongchuan Hospital of Chongqing Medical University.
2005.11-2015.11 Assistant director physician，Yongchuan Hospital of Chongqing Medical University.
2000.05-2005.11 Doctor- in- charge，Yongchuan Hospital of Chongqing Medical University.
1992.07-1999.07 Certified doctor，Yongchuan Hospital of Chongqing Medical University.
2005.07-2015.07 Deputy Director of Obsetrics and Gynecology，Yongchuan Hospital of Chongqing Medical University.
2015.07-2019.10 Director of Obsetrics and Gynecology，Yongchuan Hospital of Chongqing Medical University.
2019.10 to present Director of Gynecology，Yongchuan Hospital of Chongqing Medical University.
RESEARCH INTERESTS
I have been in more than 30 years of clinical work in Obstetrics and Gynecology.I attached great importance to the individual treatment and standardized treatment.I was proficient in standardized treatment of gynecological malignant tumors and comprehensive patient management.In the meantime，I was good at gynecological hysteroscopy and laparoscopic techniques，and Having a high level of understanding and control over Haifu Micro non-invasive Treatment Technology.
HONOUR & AWARDS
2014.9 I was awarded Prominent teacher in Chongqing Medical University.
2017.9 I was awarded Prominent teacher in Chongqing Medical University.
2018.9 I was awarded Prominent teacher in Chongqing Medical University.
PUBLICATIONS
Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer,Oncotarget,2017.2,8(9)14655～14665.
A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma,American Journal of Translational Research,2016.2,8(2):719～737.
